Iopromide

Description

Iopromide is an X-ray contrast agent for intravascular use. It gives radiographic visualization of the internal structures and hence used for many intra-arterial and intravenous procedures.

Side effects

Major & minor side effects for Iopromide

  • Headache
  • Feeling of warmth or heat
  • Back pain
  • Chest pain
  • Abnormal vision
  • Frequent urge to urinate
  • Pale skin at injection site
  • Decreased heart rate
  • Nausea or Vomiting
  • Increased thirst
  • Tingling of the hands or feet
  • Difficulty in breathing
  • Bluish lips or skin

Uses of Iopromide

What is it prescribed for?

  • Digital subtraction angiography
  • Cerebral arteriography
  • Visceral angiography
  • Peripheral arteriography
  • Peripheral venography
  • Coronary arteriography
  • Excretory urography
  • Contrast computed tomography
  • Left ventriculography
Read More
Concerns

Commonly asked questions

  • Onset of action
    The amount of time taken by this medicine to show its effect is subject to vary based on the individual, strength, and intended use.
  • Duration of effect
    The amount of time for which this medicine remains effective is subject to vary based on the individual, strength, and intended use.
  • Safe with alcohol?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is it habit forming?
    No habit-forming tendencies were reported.
  • Usage in pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.
  • Usage while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.

Allergy

This medicine is not recommended for use if you have a known allergy to iopromide or any other inactive ingredients present along with it.

Intrathecal Administration

This medicine is not recommended for intrathecal administration (into the spine).

Preparatory dehydration

Prolonged fasting and bowel preparation before Iopromide is not recommended in children due to the risk of kidney failure.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.
General warnings

Kidney injury

Use of Iopromide may increase the risk of kidney injury and hence should be used with caution in patients with kidney diseases due to the risk of worsening of the patient's condition. Close monitoring of kidney function, appropriate dose adjustments, or replacement with a suitable alternative might be required in some cases.

Hyperthyroidism

Iopromide should be done with caution in patients with hyperthyroidism due to the risk of worsening of the patient's condition. Close monitoring of thyroid function, appropriate dose adjustments, or replacement with a suitable alternative might be required in some cases.

Severe local tissue damage

Extravasation during injection may result in severe local tissue damage in some patients. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

Severe cutaneous adverse reactions

Use of Iopromide may cause severe cutaneous adverse reactions including Stevens-Johnson syndrome, toxic epidermal necrolysis, etc. in some patients. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

Anaphylactoid reactions

Use of Iopromide may cause fatal anaphylactoid reactions, especially in patients with allergic disorders. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

Missed Dose

Since Iopromide is given during procedures, therefore the likelihood of missing a dose is very less.

Overdose

Since Iopromide is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of an overdose is very less. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Beta blockers

Cyclosporine

Ibuprofen

Disease interactions

Disease

Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
Iopromide is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Effect on sleep is not established

How it works
Iopromide helps to visualize the blood vessels more clearly.
Legal Status

Approved

Unknown

Approved

Unknown

Classification

Category

Non-ionic iodinated contrast media, Diagnostic radiopharmaceuticals

Schedule

Schedule H

[Internet]. Drugbank.ca. 2018 [cited 28 December 2018]. Available from:

https://www.drugbank.ca/drugs/DB09156

[Internet]. Resources.bayer.com.au. 2019 [cited 25 February 2019]. Available from:

https://resources.bayer.com.au/resources/uploads/PI/file9435.pdf

[Internet]. Accessdata.fda.gov. 2018 [cited 28 December 2018]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20220scp018_ultravist_lbl.pdf

[Internet]. 2018 [cited 28 December 2018]. Available from:

https://medsafe.govt.nz/Consumers/CMI/u/ultravist.pdf

[Internet]. Radiologysolutions.bayer.com. 2019 [cited 25 February 2019]. Available from:

https://www.radiologysolutions.bayer.com/products/ct/ultravist/

How will this medicine affect me?

Consult top doctors online and get an answer now
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now
Something doesn’t feel right?
Report an error

Information on this page was last updated on 26 Feb 2019

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.